Bio-equivalent test required for special dosage formed drugs.

Published: 2000-11-07 17:52:00

Updated: 2000-11-07 17:52:00

Mr. Yang Kyu-whan, the head administrator of the KFDA reported in the Parliamentary Inspection of Government administration that cardiac, anti-cancer and anti-convulsant drugs, a relatively narrow range of its safety, and special dosage formed drugs like a sustained releasing tablets or inhalent ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK